Allergan Plc said it expects revenue at its medical aesthetics unit to grow to $7 to $8 billion by 2025, even as it faces increasing competition for its blockbuster wrinkle treatment, Botox.
Source:: Reuters – Business News
Allergan Plc said it expects revenue at its medical aesthetics unit to grow to $7 to $8 billion by 2025, even as it faces increasing competition for its blockbuster wrinkle treatment, Botox.
Source:: Reuters – Business News
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.